Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

InspireMD (NSPR) Restructuring Costs (2024 - 2025)

InspireMD (NSPR) has 3 years of Restructuring Costs data on record, last reported at $1.8 million in Q3 2025.

  • For Q3 2025, Restructuring Costs rose 60.53% year-over-year to $1.8 million; the TTM value through Sep 2025 reached $6.2 million, up 104.41%, while the annual FY2024 figure was $4.6 million, 4.79% up from the prior year.
  • Restructuring Costs reached $1.8 million in Q3 2025 per NSPR's latest filing, up from $1.8 million in the prior quarter.
  • Across five years, Restructuring Costs topped out at $1.8 million in Q3 2025 and bottomed at $1.1 million in Q4 2024.